No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Feng Chi Biotech Corp., a company based in Taipei, Taiwan, specializes in offering a diverse range of diagnostic and scientific services. Their core activities encompass genetic screening for both pre-implantation and prenatal stages, comprehensive life science support, and early detection screening for newborns. Additionally, they perform microbiological assessments for the food and pharmaceutical sectors, alongside engaging in medical translational research. The company also acts as a supplier for various genetic testing technologies and products specifically tailored for the field of oncology.
www.fcbiotech.com.twNo one on the platform currently holds 6744.TWO.
No tracked institution reports a position in 6744.TWO as of their last filing.
No one on the platform has traded 6744.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 6744.TWOFeng Chi Biotech Corp. | $14.70 | -1.67% | $226M | — |
| 4170.TWOVectorite Biomedical Inc. | $12.55 | +0.80% | $549M | — |
| 4183.TWOEPS Bio Technology Corp. | $13.05 | -1.14% | $311M | — |
| 4197.TWOVisgeneer Inc. | $9.24 | +0.54% | $279M | — |
| 6549.TWOTaiwanJ Pharmaceuticals Co., Ltd. | $6.93 | +0.43% | $555M | — |
| 6621.TWOUniPharma Co., Ltd. | $11.55 | +0.43% | $416M | — |
| 6661.TWOWelgene Biotech Co.,Ltd. | $16.00 | -3.61% | $373M | — |
Source: Financial Modeling Prep · peers by sector/industry